a.reyes
TL4 Administrator Co-founder · Governance · Lisbon, PT
Co-founded The Peptide Commons in May 2024 to see whether a peptide community could be run in the open. I write and maintain the guidelines, publish the moderation log, and answer anything about how this place is governed. I am not a clinician and I do not give dosing advice.
Joined 18 May 2024 · last posted 21h · groups: staff, moderators, wiki-editors, trust-level-4
205Posts here
7Topics
2Solutions
1.7kLikes received
1.3kLikes given
37Badges
204Days visited
6.6kPosts read
Stated areas
Recent activity
Full stream-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #100 · Access › Insurance & coverage · 27 Jul 2026 · 3 likes Coming back to post #98, because the follow-up matters more than the original answer. Generic versus brand: most of these compounds do not have generic versions yet.…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #27 · Analytics › COA interpretation · 27 Jul 2026 · 0 likes Picking up post #24: that is the part I would want checked first. Purity and content are different measurements: purity tells you what proportion of the detected…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #29 · Compounds › Oral incretins · 26 Jul 2026 · 20 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Seven-day rolling means and why weekly readings mislead Replied, post #94 · Outcomes › Progress reports · 23 Jul 2026 · 5 likes Coming back to post #92, because the follow-up matters more than the original answer. Measurement noise: day-to-day body mass varies by more than a kilogram on…
-
How shortages have affected compounding permissions Replied, post #62 · Access › Shortages · 23 Jul 2026 · 12 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Priming a pen and whether the primed volume is wasted Replied, post #19 · Devices › Pens & autoinjectors · 23 Jul 2026 · 2 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #50 · Compounds › Secretagogues & GH axis · 23 Jul 2026 · 10 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Seven-day rolling means and why weekly readings mislead Replied, post #75 · Outcomes › Progress reports · 21 Jul 2026 · 3 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #28 · Sourcing › Vendor reports · 20 Jul 2026 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #16 · Analytics › COA interpretation · 17 Jul 2026 · 18 likes post #15 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 15 Jul 2026 · 11 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #21 · Practice › Side effects · 14 Jul 2026 · 18 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
Maintains 3 documents
- Exenatide — referenceReview due 5 Dec 2026
- SURPASS-2 — trial digestReview due 1 Sep 2026
- Cagrilintide plus semaglutide phase 2 — trial digestReview due 16 Nov 2026